1,290 Shares in Agilent Technologies, Inc. (NYSE:A) Purchased by Gibson Capital LLC

Gibson Capital LLC purchased a new position in Agilent Technologies, Inc. (NYSE:A) during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 1,290 shares of the medical research company’s stock, valued at approximately $188,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Livelsberger Financial Advisory purchased a new stake in shares of Agilent Technologies in the fourth quarter worth about $26,000. MV Capital Management Inc. grew its stake in shares of Agilent Technologies by 120.7% during the 4th quarter. MV Capital Management Inc. now owns 192 shares of the medical research company’s stock worth $27,000 after purchasing an additional 105 shares during the period. VisionPoint Advisory Group LLC acquired a new stake in shares of Agilent Technologies during the 4th quarter worth approximately $29,000. Rise Advisors LLC lifted its stake in shares of Agilent Technologies by 527.8% in the 1st quarter. Rise Advisors LLC now owns 226 shares of the medical research company’s stock valued at $33,000 after purchasing an additional 190 shares during the period. Finally, Baystate Wealth Management LLC boosted its holdings in Agilent Technologies by 107.3% during the fourth quarter. Baystate Wealth Management LLC now owns 257 shares of the medical research company’s stock worth $36,000 after buying an additional 133 shares in the last quarter.

Agilent Technologies Trading Down 0.9 %

Shares of NYSE:A traded down $1.17 during midday trading on Friday, reaching $129.63. 9,817,612 shares of the company’s stock were exchanged, compared to its average volume of 2,591,764. The stock has a market cap of $37.82 billion, a price-to-earnings ratio of 30.65, a P/E/G ratio of 4.40 and a beta of 1.07. Agilent Technologies, Inc. has a fifty-two week low of $96.80 and a fifty-two week high of $155.35. The firm’s 50 day simple moving average is $139.56 and its two-hundred day simple moving average is $138.47. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.15 and a quick ratio of 1.64.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, May 29th. The medical research company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.19 by $0.03. The business had revenue of $1.57 billion during the quarter, compared to analyst estimates of $1.58 billion. Agilent Technologies had a return on equity of 26.25% and a net margin of 18.84%. During the same period last year, the business posted $1.27 earnings per share. The company’s quarterly revenue was down 8.4% on a year-over-year basis. As a group, sell-side analysts forecast that Agilent Technologies, Inc. will post 5.25 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 24th. Investors of record on Tuesday, July 2nd will be paid a dividend of $0.236 per share. The ex-dividend date is Tuesday, July 2nd. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.73%. Agilent Technologies’s payout ratio is 22.22%.

Insider Activity at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,958 shares of the business’s stock in a transaction on Monday, June 3rd. The shares were sold at an average price of $130.00, for a total transaction of $254,540.00. Following the completion of the transaction, the chief executive officer now owns 25,185 shares in the company, valued at $3,274,050. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, SVP Dominique Grau sold 15,000 shares of the business’s stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $133.28, for a total transaction of $1,999,200.00. Following the completion of the sale, the senior vice president now owns 49,486 shares in the company, valued at approximately $6,595,494.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Padraig Mcdonnell sold 1,958 shares of the company’s stock in a transaction on Monday, June 3rd. The shares were sold at an average price of $130.00, for a total transaction of $254,540.00. Following the completion of the transaction, the chief executive officer now owns 25,185 shares of the company’s stock, valued at approximately $3,274,050. The disclosure for this sale can be found here.

Analyst Ratings Changes

A number of research analysts have weighed in on the stock. Stifel Nicolaus decreased their price objective on shares of Agilent Technologies from $163.00 to $151.00 and set a “buy” rating for the company in a research report on Thursday, May 30th. TD Cowen reduced their price target on Agilent Technologies from $163.00 to $153.00 and set a “buy” rating for the company in a report on Thursday, May 30th. JPMorgan Chase & Co. dropped their price objective on Agilent Technologies from $165.00 to $155.00 and set an “overweight” rating on the stock in a report on Thursday, May 30th. Jefferies Financial Group reaffirmed a “hold” rating and set a $135.00 target price (down from $152.00) on shares of Agilent Technologies in a research note on Monday, June 3rd. Finally, UBS Group dropped their price target on shares of Agilent Technologies from $155.00 to $141.00 and set a “neutral” rating on the stock in a research note on Thursday, May 30th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and nine have given a buy rating to the company’s stock. According to data from MarketBeat, Agilent Technologies has an average rating of “Hold” and an average price target of $136.88.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.